Picture of Calumet logo

CLMT — Calumet News Story

0.000.00%
us flag iconLast trade - 00:00
EnergyAdventurousLarge CapNeutral

Calumet Q2 sales beat estimates on demand for specialty products

Calumet Q2 sales beat estimates on demand for specialty products


Overview

  • US specialty products and renewable fuels maker's Q2 sales rose, beating analyst expectations

  • Q2 net loss narrows

  • Adjusted EBITDA more than doubled from last year


Outlook

  • Company expects to accelerate deleveraging and advance growth strategies across both businesses

  • Calumet sees a favorable margin environment in specialty products and renewables

  • Company remains focused on using cash from operations to pay down debt in future periods


Result Drivers

  • SPECIALTY SHORTAGE - Co said global shortage in specialty products, strong production and commercial execution drove Specialty Products & Solutions results

  • RENEWABLES EXPANSION - Montana Renewables completed first phase of MaxSAF 150 expansion and restarted operations in May, capturing robust renewable margins

  • PERFORMANCE BRANDS MARGIN PRESSURE - Record TruFuel sales offset by compressed margins due to price lag and higher feedstock costs


Company press release: ID:nPn1GrQTwa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$1.45 bln

$1.08 bln (4 Analysts)

Q2 Loss Per Share

$1.09

Q2 Net Loss

$95.90 mln

Q2 Adjusted EBITDA

$159.30 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the oil & gas refining and marketing peer group is "buy"

  • Wall Street's median 12-month price target for Calumet, Inc. is $36.00, about 14% below its August 6 closing price of $41.88


Reuters Recommended Reads

  • Aug 6 - Renewable fuels maker Gevo's Q2 revenue slightly beats estimates, lifts FY EBITDA outlook

  • Aug 5 - Montauk Renewables Q2 revenue beats estimates on higher RINs sales


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Calumet

See all news